JFB provides tools and guidance to help editors manage fertility biomarker submissions efficiently.

Resources focus on standardized review workflows, ethical compliance, and reporting quality.

• Confirm scope fit and fertility biomarker relevance early
• Match reviewers to reproductive, laboratory, or imaging expertise
• Verify ethics approvals and consent documentation
• Request clarity on assay methods and treatment protocols
• Monitor review timelines and follow up promptly
• Encourage consistent decision letters and clear revision guidance.
• Ensure reviewer expertise matches fertility biomarker subtopics.
• Confirm ethics approvals and patient consent documentation.
• Monitor turnaround times and communicate delays promptly.
• Promote data transparency and reproducibility statements.
• Document conflicts of interest and recuse when needed.
• Coordinate with guest editors to align on scope fit.
• Verify clinical trial registration and reporting quality.
• Ensure statistical review for complex biomarker studies.
• Request data access statements for sensitive clinical datasets.
• Encourage adherence to CONSORT, STROBE, PRISMA, or CARE.
• Check that imaging and laboratory reporting are adequate.
• Ensure conclusions align with data and avoid overstatement.
• Promote clear reporting of treatment protocols and laboratory methods.
• Encourage reporting of outcome definitions and risk stratification.
• Verify that assay validation and sample timing details are complete.
• Request clarification on imaging criteria and response assessments.

JFB is committed to rigorous, transparent publishing in fertility biomarker research and reproductive medicine. We emphasize reproducible laboratory methods, clear reporting of diagnostic criteria, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in biomarker validation, reproductive outcomes, and translational fertility science.